The BioCentury London index was up 18% in 3Q13, and the BioCentury Europe index was up 12%. Thirteen of 14 U.K.-listed companies in the market cap-weighted London index advanced last quarter. In particular, Vectura Group plc (LSE:VEC) gained 37% to £372.5 million ($598.8 million). In July, EMA's CHMP